NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

“Certainly the short position doesn't seem to be on the sidelines, as they anticipate Northwest won't even apply...”

They know as well that U.K. approvals are coming, but they won’t admit it. Once the UK approvals come through, they will just find something else to complain about like reimbursements, scaling the operations, investment needed, etc. And these are all valid questions and concerns. So they will likely short again if at all there is another brief spike over a dollar upon UK approval (and there is no indication of a big pharma partnership). The shorts also know that big dilution will be needed to fund existing debt and ongoing expansion in the coming months so thats another opportunity for them to slam it down. Retail alone is not going to be the answer to counter shorts in a meaningful way. It hasn’t worked so far with all these important milestones and it won’t in the coming months.